Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Change in Management Team: Anton Jacobsson to leave Musti Group

Musti Group plc Stock Exchange Release 13 May 2020 at 11.30 a.m.Anton Jacobsson, Head of eCommerce and Omnichannel, has decided to resign from his position in Musti Group. His last employment day at Musti Group will be 30 September 2020. As a result of the change, the responsibility for the Omnichannel development will be divided to each country director in Finland, Sweden and Norway. Group CEO David Rönnberg: ‘I want to thank Anton for all the work he has done in developing Musti’s omnichannel strategy to the high current level during these years. The change and integration to country

Bambuser enters into agreement with Odd Molly for Live Video Shopping

Bambuser AB has entered into a minor agreement with Odd Molly International AB (publ) regarding a limited version of Live Video Shopping for retail. The agreement runs for six months without the possibility of an extension, however, with the possibility of upgrading to the full version during or after the agreement expires. Bambuser judges that the revenue from the agreement is low in relation to previously entered into agreements.Since Bambuser's launch of the new product Live Video Shopping last fall, the new technology has been met with a great interest in various industries. Bambuser

Peab builds apartments in Espoo

Peab has been commissioned to build 137 apartments on Uuno Kailas Road 4 in Espoo for the Kojamo Group. The contract is worth EUR 15 million.The project consists of a high-rise with five to eight floors and four staircases with 137 high class apartments with one to four rooms. Peab has previously built homes for Kojamo in the same tract. “In recent years we have built a number of high class high rises in the capital city region together with Kojamo. We are very pleased that our excellent cooperation will continue in this project and that we can contribute to fulfilling the need for more

Wärtsilä Fuel Efficiency Boost will reduce both fuel consumption and greenhouse gas emissions for four KOTC VLCCs

Wärtsilä Corporation, Trade press release, 13 May 2020 at 10 am EESTThe technology group Wärtsilä has been contracted to upgrade the performance of four vessels owned by Kuwait Oil Tanker Company (KOTC), a subsidiary of Kuwait Petroleum Company (KPC), by retrofitting the Wärtsilä Fuel Efficiency Boost  solution to the ships’ main engines. The modification will reduce fuel consumption, and correspondingly lessen the environmental impact by lowering greenhouse gas emission levels. The order with Wärtsilä was placed in the first

Atea Sweden wins large new public sector frame agreement

Atea Sweden has been awarded a frame agreement from the public sector purchasing agency Statens Inköpscentral Kammarkollegiet. The frame agreement has three parts which cover client devices (PCs, tablets and mobile phones), as well as related services and accessories. Atea has been awarded as a supplier on all three parts of the frame agreement.  The agreement has an estimated annual value of approximately SEK 1.6 billion per year. The frame agreement has an initial term of 2 years, and may be extended by the customer for an additional two years.  Atea is one of 5-6 suppliers on each

Report of payments to government agencies in 2019

Boliden is today publishing its report of payments to government agencies in accordance with Swedish law (2015:812) on the reporting of payments to government agencies. The report encompasses payments made to government agencies in Sweden, Finland and Ireland that pertain to extractive industry operations in 2018. This information is information that Boliden AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 08.30 CET on 13 May 2020. For further information, please contact:Klas Nilsson, Director Group

Year-end report 1 April 2019 – 31 March 2020

Fourth quarter (1 January - 31 March 2020) · Net sales increased by 6 percent and amounted to SEK 3,038 million (2,864). · Operating profit before amortisation of intangible non-current assets (EBITA) increased by 32 percent and amounted to SEK 407 million (309) corresponding to an EBITA margin of 13.4 percent (10.8). · Operating profit increased by 35 percent and amounted to SEK 352 million (260) corresponding to an operating margin of 11.6 percent (9.1). · Profit after tax increased by 47 percent and amounted to SEK 265 million (180) and earnings per share before dilution

STENOCARE – First day of trading on NASDAQ FIRST NORTH GROWTH MARKET DENMARK will be 18 May 2020

STENOCARE A/S (“STENOCARE”) has been approved for listing on Nasdaq First North Growth Market Denmark. The company hereby announce that the first day of trading will be on 18 May 2020 under the symbol “STENO”. The company will be delisted from Spotlight Stock Market and the last day of trading will be on 15 May 2020.Certified Adviser at the time of listing STENOCARE’s Certified Adviser will be Keswick Global AG, Reg. FN 332389 h, Hoffingergasse 16/1/6, 1120 Vienna, Austria, telephone number +43 (1) 533 88 90 0. Danish Law STENOCARE is a Danish company operating under Danish law,

Azelio interim report: The verification project started

The verification of Azelio’s storage technology in partnership with leading certification company DNV-GL has begun. An inauguration of Azelio’s energy storage took place at one of the world’s largest solar parks, Noor in Morocco. It was attended by government representatives, the World Bank and IFC, among others. In view of the current travel restrictions due to Covid-19 the verification will initially focus on the installation in Åmål, Sweden. Preparations for starting the verification of a further four energy storage units in Abu Dhabi, in collaboration with the company’s partners Masdar

Invitation to presentation of Embracer Group's Q4 and full-year report

Embracer Group hereby invites you to a presentation in connection with the publishing of the full-year report for fiscal year 2019/2020 and the interim report for the fourth quarter, the period January-March 2020. The report will be published at 06.00 (CET) on May 20[th].The presentation will be held in English by CEO Lars Wingefors and CFO Johan Ekström, and afterward questions are invited. Covid-19The Embracer Group safeguards stakeholders' health and strives to help limit the spread of the coronavirus, as well as comply with applicable restrictions and regulatory recommendations. As

Report for the first quarter 2020

Financial and operating highlights 1Q20 (1Q19 in brackets): · Operating revenues were NOK 1 967 million (NOK 1 687 million) · EBITDA was NOK 250 million (NOK 251 million) · Impairment in the quarter NOK 93 million (NOK 0 million) · EBIT was NOK -101 million (NOK 22 million) · Net result after tax was NOK 118 million (NOK -200 million) Segment highlights 1Q20 (1Q19 in brackets): Renewable energy · EBITDA NOK 419 mill. (NOK 384 mill.) · Total generation up 24% · Year on year decreasing electricity prices in all markets · Sale of 51% stake in GWP France,

Interim report for Q1 2020

The development of the Covid-19 pandemic has painfully highlighted the urgent need for infection prevention. This has led to an increased interest in Bactiguard and generated strong sales from mid-March. Total revenues increased by more than 40 percent in the quarter and EBITDA doubled, generating an EBITDA margin of 30 percent and a positive net result.First quarter (January-March 2020) · Revenues amounted to SEK 48,1 (33,9) million and increased by 42% (adjusted for currency 36%). · EBITDA amounted to SEK 14,4 (7,2) million with an EBITDA-margin of 30% (21%). · Operating profit

Interim Financial Report Q1-2020: First patient enrolled in Phase 3 study SPARKLE

Ascelia Pharma AB (publ) (ticker: ACE) today published its interim financial report for Q1-2020 (January – March 2020), which is now available on the company’s website: https://www.ascelia.com/tag/reports-presentations/SIGNIFICANT EVENTS IN Q1-2020 · First patient enrolled in Mangoral’s Phase 3 study SPARKLE · Additional clinical sites opened for patient enrolment · Ascelia Pharma wins the award as the best Life Science company in Malmö, Sweden SIGNIFICANT EVENTS AFTER THE PERIOD · Patent for Oncoral approved in Japan · First participant enrolled in the clinical

OssDsign AB (publ) publishes Q1 2020 interim report

The positive trend from the end of 2019 continues as OssDsign kicks off 2020 with continued  consecutive sales growth of 52% in Q1 vs Q4 2019.The first quarter in figures · Net sales amounted to TSEK 7 726 (3,514). · Loss after taxes amounted to TSEK 18 312 (17 340). · Loss per share was SEK 1,0 (1,5). · Cash flow from current operations was TSEK -21 898  (-22 547).  Important events during the first quarter ·The company has signed a new lease for the head office and  state of the art manufacturing facility in Uppsala, Sweden. · Completed transfer of the

Financial Report 2019/20 1 April 2019-31 March 2020

FINANCIAL YEAR 2019/20 (1 April 2019-31 March 2020) · Revenue increased by 2 percent to MSEK 6,135 (6,024). · EBITA (excluding items affecting comparability of MSEK –14 pertaining to costs arising from the acquisition of Swedol) rose by 6 percent to MSEK 338 (318), corresponding to an EBITA margin of 5.5 percent (5.3). · Adjusted operating profit (excluding items affecting comparability) increased to MSEK 317 (302), corresponding to an adjusted operating margin of 5.2 percent (5.0). Operating profit amounted to MSEK 303 (302) and the operating margin to 4.9 percent (5.0). ·

Hansa Biopharma to participate in five upcoming investor conferences during May and June

Hansa Biopharma has been invited to participate in five healthcare conferences during May and June including UBS Global Healthcare Conference, RBC Global Healthcare Conference, ABG Life Science Summit, Redeye Orphan Drug Event and Citi’s European Healthcare Conference.Lund, Sweden May 13, 2020. Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company’s management team will participate in the following upcoming investor conferences: · UBS Global Healthcare Conference on Monday, May 18, 2020, with a presentation at

MAG moves publication date of the Q3 interim report

Stockholm, Sweden - 13 May - The Board of Directors of MAG Interactive AB (publ) has decided to move the publication of the interim report for the period September 1, 2019 - May 31, 2020 from July 1, 2020 to June 30, 2020. The decision was made to enable those in leadership positions within the company to exercise warrants within the framework of the warrants program 2017/20:1 during a slightly extended portion of the exercise period.

Gas filling station network expands to Järvenpää in Finland

Energy company Gasum is to build the first gas filling station in Järvenpää, in the Boogie business district. The new gas filling station will enjoy an excellent location at a traffic hub and will strengthen Gasum’s network of stations, especially in Central Uusimaa. The City of Järvenpää is striving for carbon neutrality by 2035 as part of the Resource Wisdom Järvenpää project, and the new filling station will contribute to promoting this objective. The gas filling station is expected to open by the end of 2020.Gasum is further strengthening its gas filling station network in Southern

Bactiguard appoints Gabriella Björknert Caracciolo as new CFO

Bactiguard Holding AB (publ) has appointed Gabriella Björknert Caracciolo, currently Head of Strategy, Development and Governance within Transaction Banking, Nordea as new CFO and Executive Vice President. She succeeds Cecilia Edström, who in February was appointed CEO of the company. Gabriella Björknert Caracciolo assumes her new position in August 2020.“Gabriella Caracciolo is an experienced and development oriented leader with a strong business focus and broad experience. Her financial skills are solid, and she has extensive experience in driving business transformations. These are

Notice to the Annual General Meeting of Basware Corporation

Basware Corporation, stock exchange release, May 13, 2020 at 8.30 am EESTNotice is given to the shareholders of Basware Corporation to the Annual General Meeting to be held on 4 June, 2020 at 1:00 PM at the company’s headquarters, at the address Linnoitustie 2, Cello-rakennus, 02601 Espoo, Finland. Basware takes the coronavirus situation very seriously and aims to ensure the best interests of the company and its shareholders by holding the Annual General Meeting on 4 June, 2020. The company will impose several precautionary measures to be able to hold the meeting and to ensure the safety

Ferronordic AB (publ) Interim Report January - March 2020

Growth in Russia/CIS. Start of operations in GermanyFIRST QUARTER 2020 · Revenue increased by 55% to SEK 1,118m (SEK 723m) · Operating profit decreased by 9% to SEK 51m (SEK 56m) · Operating margin decreased to 4.6% (7.7%) · The result for the period decreased by 56% to SEK 20m (SEK 46m) · Earnings per ordinary share amounted to SEK 1.39 (SEK 3.19) · Cash flows from operating activities amounted to SEK 101m (SEK -116m) SEK M Q1 Q1 % 2020* 2019Revenue 1 118 723 55%Operating profit

Sprint Bioscience announces the identity of the target protein in the wholly-owned project VADA

Sprint Bioscience today announces that after a series of preclinical research advances in the VADA project, it has been decided to publish the project's target protein. The goal is to develop drug substances that inhibit the protein vaccinia-related kinase 1 (VRK1) in order to enhance the effects of immuno-oncology therapy, radiation therapy and chemotherapy. The company believes that this approach paves the way for a unique position in the market for innovative drug projects and will now initiate contacts with potential partners.The new target protein VRK1 acts by regulating the activity

There are no items matching the current filter
There are no more items matching the current filter
Back to top